Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups (original) (raw)
Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome
ahmet isik
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001
View PDFchevron_right
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
Evangelos Papanikolaou, Michel Camus
Fertility and Sterility, 2006
View PDFchevron_right
An update on the prevention of ovarian hyperstimulation syndrome
Julia Kopeika
Women's Health, 2016
View PDFchevron_right
Minimal monitoring of ovarian hyperstimulation: a useful simplification of the clinical phase of in vitro fertilization treatment
Arne van Heusden
Fertility and Sterility, 1995
View PDFchevron_right
Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles
Yu-shih Yang
Human …, 2008
View PDFchevron_right
Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles
Elba Mejia
Journal of International Medical Research
View PDFchevron_right
Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others?
Neil McClure
Human Reproduction, 2002
View PDFchevron_right
Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patients
sajid hussain
Human Reproduction, 2001
View PDFchevron_right
Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr
Murat Arslan
Fertility and Sterility, 2005
View PDFchevron_right
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
Goran Vujić
ACTA CLINICA CROATICA
View PDFchevron_right
Avoiding Ovarian Hyperstimulation Syndrome - Current Primary and Secondary Preventive Strategies
Maren Goeckenjan
Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology
View PDFchevron_right
CLINICAL ASSISTED REPRODUCTION: Determination of the Efficiency of Controlled Ovarian Hyperstimulation in the Gonadotropin-Releasing Hormone Agonist-Suppression Cycle Using the Initial Follicle Count During Gonadotropin Stimulation
Hsueh-wen Chang
2001
View PDFchevron_right
A new treatment to avoid severe ovarian hyperstimulation utilizing insights from in vitro maturation therapy
Bruce Rose
Journal of Assisted Reproduction and Genetics, 2013
View PDFchevron_right
Controlled ovarian hyperstimulation: Does prolonged stimulation justify cancellation ofin vitrofertilization cycles?
Raoul Orvieto
Gynecological Endocrinology, 2005
View PDFchevron_right
Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment
P. Egbase
Human Reproduction, 2000
View PDFchevron_right
Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
Raoul Orvieto
Journal of ovarian research, 2013
View PDFchevron_right
Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization
Anders Enskog
Fertility and Sterility, 1999
View PDFchevron_right
Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome
Dean Morbeck
Fertility and Sterility, 2010
View PDFchevron_right
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
Annick Delvigne
Human Reproduction Update, 2002
View PDFchevron_right
What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study
Yvon Englert
Journal of Assisted Reproduction and Genetics, 2017
View PDFchevron_right
Reply: Can we eliminate severe ovarian hyperstimulation syndrome?
Seang Lin Tan
Human Reproduction, 2005
View PDFchevron_right
Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization
Martha Aguirre
Fertility and Sterility, 2005
View PDFchevron_right
Can we eliminate severe ovarian hyperstimulation syndrome?
Raoul Orvieto
Human Reproduction, 2005
View PDFchevron_right
Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient
Peter McGovern
Human Reproduction, 1998
View PDFchevron_right
Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization
K. Pruksananonda
American Journal of Health-System Pharmacy, 2008
View PDFchevron_right
The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: A prospective randomized study
Howard Jacobs
International Journal of Gynecology & Obstetrics, 1993
View PDFchevron_right
Ovarian hyperstimulation syndrome: pathophysiology and prevention
Rui Ferriani
Journal of Assisted Reproduction and Genetics, 2010
View PDFchevron_right
In Vitro Maturation of Oocytes in Women at Risk of Ovarian Hyperstimulation Syndrome-A Prospective Multicenter Cohort Study
international journal of fertility and sterility Int J Fertil Steril
Volume 13, Number 1, Apr-Jun 2019 Pages: 38-44, 2019
View PDFchevron_right
Prevention and management of ovarian hyperstimulation syndrome
Nikos Vlahos
Obstetrics, Gynaecology & Reproductive Medicine, 2011
View PDFchevron_right
High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization
Bernadette Mannaerts
Human Reproduction, 1998
View PDFchevron_right